Desq Long
Sign in

Cluster

GRCE-2026-09-08-80f561c90bc2

SEC FORM 4CLUSTER · 2 INSIDERS
$245,895.66

Grace Therapeutics, Inc. (GRCE)

Purchase of 115,229 shares across 2 reporting persons.

Transaction Code P · Reporting Persons 2

  • Kohli Prashant, Chief Executive OfficerPurchase of 100,000 shares at $2.14 per share.$214,000.00
  • Opaleye Management Inc.Purchase of 9,393 shares at $2.0972 per share.$19,699.00
  • Opaleye Management Inc.Purchase of 5,836 shares at $2.0899 per share.$12,196.66

Surfaced by rule: 2 distinct insiders, open-market purchases, 7-day window — a deterministic filter, not a recommendation.

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001140361-26-036125 · filed 2026-09-10 · View filing →

Source: SEC Form 4 · 0001493152-26-042152 · filed 2026-09-10 · View filing →

Permalink →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Grace Therapeutics, Inc. (GRCE)." Disclosed 2026-09-10. https://desqlong.com/cards/cluster-GRCE-2026-09-08-80f561c90bc2 (retrieved 2026-09-26).